• IP-MS Validated OPA3 Polyclonal Antibody
    • Cat#: MSVAB-14782
    • Primary Applications: IP, Co-IP, IP-MS
    • Species Reactivity: Human, Mouse, Rat, Bovine
    • Antibody Specificity: OPA3
    • Other Applications: WB, IHC, IF, ICC, ELISA

    Customer Support Program

    • First-time antibody customers may receive IP-MS identification for one sample at no additional cost with their first antibody purchase.
    • Customers who purchase antibodies may receive 10% off subsequent IP-MS identification services.
  • -
    1
    +
    Add to Cart

Target Information

Target informationOptic atrophy 3 protein (OPA3), also known as MGA3, is a mitochondrial membrane-associated protein involved in mitochondrial morphology, membrane organization, and cellular energy homeostasis. OPA3 is studied in mitochondrial dynamics, optic atrophy, and metabolic regulation, and it plays a role in mitochondrial quality control and organelle-associated protein interactions. IP-MS Validated OPA3 Polyclonal Antibody from MtoZ Biolabs enables selective enrichment of OPA3 prior to mass spectrometry analysis. This OPA3 antibody validated by IP-MS supports studies of mitochondrial organization, OPA3-associated protein complexes, and mitochondrial regulatory pathways. Researchers can use an OPA3 IP antibody, an OPA3 antibody for immunoprecipitation, or an OPA3 antibody in IP-MS workflows for target capture and downstream proteomic characterization.
Target nameoptic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
AliasesOptic atrophy 3 protein, MGA3
UniProt accessionQ9H6K4

Product Introduction

Primary applications
  • IP (Immunoprecipitation)
  • Co-IP (Co-Immunoprecipitation)
  • IP-MS (Immunoprecipitation-Mass Spectrometry)

Before delivery, each antibody undergoes IP-MS validation to verify its ability to recognize and enrich the intended target protein

Other applicationsWB, IHC, IF, ICC, ELISA
Species reactivityHuman, Mouse, Rat, Bovine
ClonalityPolyclonal
HostRabbit
Recommended dilution ratioIP: 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Specification50 μL,100 μL,150 μL
Storage conditionShort-term storage at 2-8 °C. Long-term storage at -20 °C. Avoid repeated freeze-thaw cycles

MtoZ Biolabs IP-MS Workflow Products

MtoZ Biolabs offers a fully integrated IP-MS workflow solution, combining antibodies validated for IP-MS with expertly paired IP kits and seamless downstream mass spectrometry services. Our platform empowers researchers to achieve reliable target enrichment, protein interaction mapping, and comprehensive proteomic profiling with confidence and efficiency.

IP-MS Validated Antibodies

  • Antibodies rigorously tested for IP-MS applications
  • Minimize experimental uncertainty and accelerate research timelines
  • Broad applicability across multiple species and protein targets

Expertly Paired IP Kits

  • Designed and validated to complement MtoZ IP-MS antibodies
  • Detailed step-by-step experimental protocols for reproducible target enrichment
  • Optimized workflows to maximize antibody performance

Comprehensive IP-MS Analysis Services

  • Submit immunoprecipitated samples directly to MtoZ Biolabs
  • High-resolution mass spectrometry for target verification, interaction mapping, and proteomics studies
  • Structured, publication-ready reports for seamless documentation and data reproducibility

Antibody Validation Levels

To support different research goals, budgets, and evidence requirements, our antibodies are available with multiple validation levels. Each antibody undergoes IP-MS validation before delivery to confirm target-specific recognition and enrichment. For projects requiring additional confirmation, Western blot validation can be added to provide orthogonal evidence of target detection.

Validation levelIncluded validationBest for
IP-MS OnlyConfirms target-specific enrichment by immunoprecipitation followed by mass spectrometry analysis.IP-based protein enrichment and target specificity assessment.
Western Blot OnlyConfirms target detection by Western blot under defined experimental conditions.Routine target detection and expression-level assessment.
IP-MS + Western BlotCombines mass spectrometry-based target enrichment evidence with Western blot-based detection evidence.Customers requiring more comprehensive validation support.

Antibody Validation Workflow

https://file.brightmindcrm.com/dev/mtoz-product/20260522/article/2057637939214188544-20260521-161303.png

Validation Report Included

IP-MS

  • IP experiment record
  • Antibody usage information
  • Original experimental image
  • Mass spectrometry parameters
  • Identified target peptides
  • Representative MS/MS spectra

Western Blot

  • WB experimental conditions
  • Original blot image
  • Qualitative target band recognition result

MtoZ Biolabs IP-MS Antibody Solutions

Traditional Antibody Supplier

Conventional workflow
  • Customers need to purchase small amounts of antibody for in-house testing

    01
  • Validation depends on customer-provided samples and workflows

    02
  • Suppliers usually stop support after product delivery

    03
  • Customers must find a separate provider for MS or interaction analysis

    04
  • Higher risk of repeated trial-and-error

    05

MtoZ Biolabs IP-MS Antibody Solutions

Recommended
  • MtoZ Biolabs can provide IP-MS validation before or at the time of purchase

    01
  • Validation is supported by MS-based evidence and a detailed report

    02
  • Antibody purchase can be directly connected to downstream IP-MS services

    03
  • Antibody and downstream IP-MS analysis can be completed within a single workflow

    04
  • Reduces trial attempts and accelerates project progress

    05

Why Choose MtoZ Biolabs?

0+

Antibodies Validated

0+

Target Proteins

0+

Research Institutions Served

Full Validation Reports Included

Structured IP/Co-IP/IP-MS validation reports are included with every antibody for easy lab recordkeeping and project documentation.

Ultra-High Resolution MS Platform

IP-MS validation on high-resolution LC-MS/MS instrumentation for confident target enrichment and specificity assessment.

FAQ

IP-MS validation means that the antibody is first used to pull down proteins from a cell lysate, and the captured proteins are then analyzed by mass spectrometry. This helps confirm whether the antibody can recognize and enrich its intended target protein, instead of mainly pulling down unrelated background proteins.
IP-MS validation does not require a long additional wait. Based on our optimized workflow, it typically adds no more than 5 to 7 business days to the standard processing time. After validation is completed, the antibody and validation report are delivered together.
The validation report includes key experimental records, workflow details, antibody usage information, mass spectrometry settings, target protein identification results, and signal intensity evaluation. The report provides clear supporting data that customers can review and use for project documentation.
We use an ultra-high resolution mass spectrometry platform for IP-MS validation. This platform supports accurate protein identification and provides reliable peptide-level evidence for reviewing antibody validation results.
Submit Inquiry
Name *
Email Address *
Phone Number
Inquiry Project *
Project Description